- Home
- PBHC vs COEP Comparison
PBHC vs COEP Comparison
Compare PBHC & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- COEP
- Stock Information
- Founded
- PBHC 1859
- COEP 2017
- Country
- PBHC United States
- COEP United States
- Employees
- PBHC N/A
- COEP N/A
- Industry
- PBHC Major Banks
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PBHC Finance
- COEP Health Care
- Exchange
- PBHC Nasdaq
- COEP Nasdaq
- Market Cap
- PBHC 92.9M
- COEP 86.0M
- IPO Year
- PBHC N/A
- COEP N/A
- Fundamental
- Price
- PBHC $15.14
- COEP $14.96
- Analyst Decision
- PBHC
- COEP
- Analyst Count
- PBHC 0
- COEP 0
- Target Price
- PBHC N/A
- COEP N/A
- AVG Volume (30 Days)
- PBHC 6.2K
- COEP 40.8K
- Earning Date
- PBHC 10-31-2025
- COEP 11-12-2025
- Dividend Yield
- PBHC 2.64%
- COEP N/A
- EPS Growth
- PBHC N/A
- COEP N/A
- EPS
- PBHC 0.28
- COEP N/A
- Revenue
- PBHC $39,015,000.00
- COEP $263,555.00
- Revenue This Year
- PBHC N/A
- COEP N/A
- Revenue Next Year
- PBHC N/A
- COEP N/A
- P/E Ratio
- PBHC $53.94
- COEP N/A
- Revenue Growth
- PBHC N/A
- COEP N/A
- 52 Week Low
- PBHC $13.55
- COEP $2.31
- 52 Week High
- PBHC $18.53
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- PBHC 50.29
- COEP 47.93
- Support Level
- PBHC $14.65
- COEP $14.68
- Resistance Level
- PBHC $15.20
- COEP $16.45
- Average True Range (ATR)
- PBHC 0.18
- COEP 0.83
- MACD
- PBHC -0.04
- COEP -0.17
- Stochastic Oscillator
- PBHC 82.44
- COEP 15.42
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.